ESSA Pharma Inc is a pharmaceutical company. The company is in preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs which selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.
| Website: | www.essapharma.com |
| Main Phone: | +1 778 331-0962 |
| Address: | 999 West Broadway Street |
| Address 2: | Suite 720 |
| State: | BC |
| City / Town: | Vancouver |
| Country: | CAN |
| Postal Code: | V5Z 1K5 |
| Exchange: | NSC |
| CEO: | David R. Parkinson |
| Employees: | 15 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Last day of the Roth conference. 30 biotech companies presenting including GALT, EPIX, CLRB. Learn more about what is happening in Dana Point and what you should be watching from Equities Research
The aluminum and primary metals supplier Alcoa (AA) opened the first quarter of 2013’s earnings report season with a mixed performance.Reporting after the close of the regular trading day on
ESSA Pharma Inc is a pharmaceutical company. The company is in preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs which selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.
| Website: | www.essapharma.com |
| Main Phone: | +1 778 331-0962 |
| Address: | 999 West Broadway Street |
| Address 2: | Suite 720 |
| State: | BC |
| City / Town: | Vancouver |
| Country: | CAN |
| Postal Code: | V5Z 1K5 |
| Exchange: | NSC |
| CEO: | David R. Parkinson |
| Employees: | 15 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Last day of the Roth conference. 30 biotech companies presenting including GALT, EPIX, CLRB. Learn more about what is happening in Dana Point and what you should be watching from Equities Research
The aluminum and primary metals supplier Alcoa (AA) opened the first quarter of 2013’s earnings report season with a mixed performance.Reporting after the close of the regular trading day on
| Last Price 3.28 | Change $ -0.165 | Change % -4.79 | Tick N/A |
| Bid 3.28 | Bid Size 1,200.00 | Ask 3.43 | Ask Size 700.00 |
| Open 3.29 | High 3.29 | Low 3.28 | Prev Close 3.45 |
| Last Trade | Volume 1,039 | 52 Wk Hi 4.50 | 52 Wk Low 1.41 |
| Market Cap 68.1 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 20,762,374.00 | EPS (TTM) -1.17 | PE Ratio N/A | Exchange NCM |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 14 | 14 | 160 | 14 |
| Low Target Price Estimate | 10 | 10 | 10 | 10 |
| Mean Target Price Estimate | 12 | 12 | 61.33 | 12 |
| Standard Deviation | 2.83 | 2.83 | 85.47 | 2.83 |
| Date of Most Recent Estimate | 03/26/18 | 03/26/18 | 05/01/18 | 03/26/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 119 | 2018-05-25 |
| S-8 | Securities offered to employees under employee benefit plans | 14 | 2018-05-18 |
| S-8 POS | Post-effective amendment to an S-8 filing | 5 | 2018-05-18 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 56 | 2018-05-15 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 4 | 2018-05-11 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6 | 2018-05-08 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 4 | 2018-04-26 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6 | 2018-04-25 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 4 | 2018-04-24 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 4 | 2018-04-20 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait